TELA Bio Investor Relations Material
Latest events
Q1 2025
TELA Bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from TELA Bio Inc
Access all reports
TELA Bio Inc. is a medical technology company focused on developing and commercializing soft tissue reconstruction solutions. The company specializes in biologic and synthetic materials used in surgeries for hernia repair and abdominal wall reconstruction. TELA Bio’s products are designed to provide improved clinical outcomes by combining the strength of synthetic materials with the regenerative properties of biologic tissues. The company serves surgeons and healthcare providers, offering solutions that aim to enhance patient recovery and reduce complications. The company is headquartered in Malvern, Pennsylvania, and its shares are listed on the NASDAQ.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
TELA
Country
🇺🇸 United States